Unknown OBSERVATIONAL NCT01563484

Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media

Comparison of Liver and Renal Function After TACE for PHC With Iso-osmolar and Low-osmolar Contrast Media

Sponsor: Li Chen

Conditions Primary Hepatocellular Carcinoma

Updated 6 times since 2017 Last updated: Mar 30, 2012 Started: Mar 31, 2012 Primary completion: Sep 30, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Primary Hepatocellular Carcinoma, this trial is ongoing. The trial is conducted by Li Chen and has accumulated 6 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: PHASE2_PHASE3 → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Li Chen

Data source: Southeast University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China